BerandaDNA • NYSE
add
Ginkgo Bioworks Holdings Inc
$8,91
Setelah Jam Perdagangan Normal:(0,56%)+0,050
$8,96
Tutup: 24 Des, 16.59.58 GMT-5 · USD · NYSE · Pernyataan Penyangkalan
Tutup sebelumnya
$8,77
Rentang hari
$8,54 - $8,98
Rentang tahun
$5,00 - $17,58
Kapitalisasi pasar
513,13 jt USD
Volume Rata-Rata
1,08 jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NYSE
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 38,84 jt | -56,39% |
Biaya operasional | 114,31 jt | -11,59% |
Penghasilan bersih | -80,76 jt | -43,18% |
Margin laba bersih | -207,93 | -228,28% |
Penghasilan per saham | — | — |
EBITDA | -88,10 jt | -82,09% |
Tarif pajak efektif | 0,00% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 461,86 jt | -25,05% |
Total aset | 1,19 M | -19,70% |
Total liabilitas | 629,38 jt | -7,84% |
Total ekuitas | 559,78 jt | — |
Saham yang beredar | 56,84 jt | — |
Harga terhadap nilai buku | 0,89 | — |
Tingkat pengembalian aset | -18,24% | — |
Tingkat pengembalian modal | -21,80% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -80,76 jt | -43,18% |
Kas dari operasi | -31,61 jt | 69,46% |
Kas dari investasi | -72,82 jt | -613,88% |
Kas dari pembiayaan | 9,94 jt | 2.237,20% |
Perubahan kas bersih | -94,39 jt | 17,35% |
Arus kas bebas | 514,00 rb | 100,83% |
Tentang
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Wikipedia
CEO
Didirikan
2008
Kantor pusat
Situs
Karyawan
834
